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Abstract Background: The intestinal adaptive response
[increased epithelial cell (EC) proliferation and apopto-
sis] after massive small bowel resection (SBR) is partially
controlled by intraepithelial lymphocytes (IEL). To
identify IEL factors contributing to EC adaptation post-
SBR we utilized microarray assays. Methods: Mice
underwent a 70% SBR (SBR1w/SBR4w) or sham
operation (Sham1w/Sham4w). After 1 or 4 weeks (1w,
4w) small bowel was harvested, and IEL isolated.
Determination of the EC-proliferation rate used BrdU
incorporation, and of the EC-apoptotic rate used
Annexin V staining. Affymetrix system microarrays
(12,491 genes) were performed to examine IEL-mRNA
expression. Results were considered significant if fold-
change (FC) between groups was >2 and P <0.05
(F-test), or FC>3 and 0.05> P >0.01, or FC>4 and
P >0.05. Significant genes were confirmed by conven-
tional RT-PCR. Results: The SBR EC-proliferation
rate increased significantly in both 1w and 4w groups
compared to Sham: SBR1w 0.24±0.07 vs. Sham1w
0.12±0.02 (P =0.03); SBR4w 0.35±0.04 vs. Sham4w
0.19±0.02 (P <0.01). The EC-apoptotic rate was
unchanged in the 1w group, but significantly differed
from controls after 4 weeks: SBR4w 39.92±6.78 vs.
Sham4w 12.56±6.44 (P <0.01). Microarray results
were analyzed to identify potential growth-modifying
IEL genes. The following were identified (function in
parenthesis; A, apoptosis; P, proliferation): lipocalin 2
(promotes A), angiotensin converting enzyme (increases
A), Rap2 interacting protein (reduces A, promotes P),
amphiregulin (promotes P) and leucine-rich-a2-glyco-
protein (promotes A, reduces P). Based on RT-PCR
results these genes showed significant changes between
groups. The increase in ACE at 1w preceded the ob-
served apoptotic changes. The alterations in lipocalin 2,
Rap2 and amphiregulin at 4w coincided with the marked
changes in growth and apoptosis in the SBR mice.
Conclusions: IEL undergo temporal changes after
SBR. These findings provide profound insight into
potential IEL-dependent regulation of EC homeostasis
post-SBR.
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Introduction
Massive small bowel resection (SBR) leads to an adap-
tive response in the residual intestine. Following SBR
the remaining intestine undergoes important changes to
compensate for the loss of mucosal surface area,
whereby the epithelial cell (EC)-proliferation and
-apoptosis rates are markedly altered. After SBR, the
equilibrium of EC-proliferation and -apoptosis, which
under normal physiologic circumstances is balanced,
alters in favor of compensatory mucosal growth.
Mechanisms and mediators of intestinal adaptation
are known to be multifactorial. One of the mechanisms
of intestinal growth is thought to include the action of
intraepithelial lymphocytes (IEL). IEL secrete a variety
of cytokines and growth factors, like KGF, IFN-c,
TNF-a or IL-12, that play an important role in sus-
taining EC growth and structure [1, 2, 3]. IEL may
directly influence the regulation of the intestinal turn-
over of the EC. There is reason to believe that IEL
express even more mediators than those presently
known. To identify IEL factors contributing to EC
adaptation after SBR, we utilized microarray assays,
which allow simultaneous expression of thousands of
genes. This study focused on the expression of growth-
related genes, which might provide increased insight
into IEL function in small bowel adaptation after
massive SBR.
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Male, 2 month old, C57BL/6J mice (Jackson Laboratories, Bar
Harbor, ME) were initially fed ad libitum with normal mouse chow
and water for an acclimation period of 7 days; 24 h before surgery
chow was exchanged to micro-stabilized rodent liquid diet (Test-
Diet, Richmond, IN). Mice were divided into four groups (n =6),
and operations were performed. Anesthesia was achieved using
sodium pentobarbital (50 mg/kg body weight, intraperitoneally).
Massive small bowel resection (SBR1w/4w): Through an abdomi-
nal midline incision, 70% of the small bowel was resected (i.e.,
bowel between 3.5 cm distal to the ligament of Treitz and 3.5 cm
proximal to the ileocecal valve), followed by and an end-to-end
jejunoileal anastomosis with 7/0 monofilament, resorbable suture
[4]. Postoperatively, a subcutaneous bolus of 3 ml saline was given
to maintain intravascular hydration status. For the Sham operation
(Sham1w/4w), the intestine was transsected and re-anastomosed
without bowel resection.
Postoperatively, ad libitum water and liquid diet were reintro-
duced. If mice were not sacrificed after 1 week (w), food was
changed to standard chow. The small intestine was allowed to
adapt for 1w (SBR1w, Sham1w) or 4w (SBR4w, Sham4w) to assess
temporal changes. Animals were killed using CO2, and the intestine
was harvested.
Mucosal cell isolation
Isolation of mucosal cells was performed using a slightly modified
previously described protocol [5].Mucosal epitheliumwas harvested
from segments of intestine with an extraction buffer (l mM EDTA,
l mM dithiotheritol in phosphate buffer saline) and centrifuged. In
order to extract EC, the centrifuged pellets were purified in 20%
isotonic Percoll (Pharmacia, Piscataway, NJ). Viability exceeded
95% using trypan blue exclusion staining. The cell suspension
contained a purified mixture of EC and IEL at a ratio of 70:30.
IEL purification
Magnetic beads conjugated with antibody to CD45 (lymphocyte-
specific) were used to remove epithelial cells (BioMag SelectaPure
Anti-Mouse CD 45R Antibody Particles, Polyscience Inc., War-
rington, PA). Cells bound to beads were considered purified IEL,
and the supernatant contained EC. Flow cytometry confirmed
purity of sorted cells, which was >99%.
Microarray assay
Total RNA was isolated using Trizol (Gibco BRL, Gaithersburg,
MD) and was purified with the RNeasy Mini Kit (Qiagen, Valen-
cia, CA). Affymetrix system microarray chips (Affymetrix, Inc.,
Santa Clara, CA) allowed simultaneous interrogation of 12,491
full-length mouse genes and EST clusters from the UniGene
database. Hybridization and analysis were performed by the Uni-
versity of Michigan NIDDK Biotechnology Center. Probe-pair
measures were obtained from the images of each chip using
Microarray Suite 4.0 software (Affymetrix).
Reverse transcriptase polymerase chain reaction (RT-PCR)
IEL mRNA (poly-A positive) was reversed transcribed into cDNA
following a standard protocol [5]. Specific primers for selected gene
sequences were designed (Table 1). PCR and gel were run under
standard conditions [5]. To ensure that DNA product was generated
at the exponential portion of the product curve, the following cycle
numbers were used: 28 cycles for ACE, 32 cycles for Rap2 interacting
protein and 34 cycles for lipocalin 2, amphiregulin and leucine-rich-
a2-glycoprotein. Gel bands were analyzed by DNA sequencing
technology (University ofMichigan’s SequencingCore) to ensure the
correct product. KodakEDASSystem (Rochester, NY)was used for
imaging and quantification.Results were expressed as the ratio of the
investigated mRNA over the b-actin mRNA expression.
Epithelial cell proliferation assay
Mice were injected intraperitoneally with 5-bromodeoxyuridine
(BrdU, 50 mg/kg body weight, Roche Diagnostic Corporation, IN)
24 h before harvest. Immunohistochemical staining was performed
using the BrdU In-Situ detection Kit (BD PharMingen, San Diego,
CA). Proliferation rate is expressed as the ratio of BrdU positive
cells over the total number of epithelial cells of a crypt-villus
complex. Each assessment of proliferation consists of the mean of
14 different high power microscopic fields.
Flow cytometry
Apoptosis was determined by flow cytometry based on the cell
surface expression of phosphatidylserine (Annexin V). Annexin V
assay was performed with the Apoptosis Kit from BD PharMingen
(San Diego, CA). Staining with propidium iodide was used to
monitor cell necrosis. The apoptotic rate was determined by gating
on EC and detecting the percent of Annexin V staining as per-
centage of total EC.
Statistical analysis
Significant alteration (SBS vs. Sham) of a gene on the microarray
chip was defined as a fold-change (FC) >2 and P value<0.01
(F-test), or FC>3 and 0.05> P >0.01, or FC>4 and P >0.05.
Other results are expressed as mean ± standard deviation. These
results were analyzed using the t-test, statistical significance equals
P <0.05.
Table 1 Specific primer data.
bp base pairs Name (length of cDNA product) GeneBank
accession no.
Forward primer Reverse primer
b-actin (194 bp) NM_007393 gagggaaatcgtgcgtgacat agaaggaaggctggaaaagag














SBR1w vs. Sham1w showed a significant increase in the
proliferation rate, which was further increased after 4w
(see Table 1, Fig. 1).
EC apoptosis and necrosis
EC-apoptosis 1w postoperatively was increased in both
groups (Sham1w, SBR1w) (Table 2, Fig. 2). However,
after 4w the EC-apoptotic rate significantly differed
between groups with a persistent elevation in SBR4w
(P>0.05 vs. SBR1w) and a marked decline in the
Sham4w mice ( P =0.01 vs. Sham1w). Necrosis showed
no significant changes between all groups.
Expression of mRNA
The Affymetrix microarray chip tested for 12,491
mouse genes (Table 3). After 1w 65 genes and after 4w
254 genes were significantly changed between SBS and
sham groups, according to our criteria. These genes
were analyzed for their function, and factors related to
growth regulation were chosen for confirmation by RT-
PCR. The following IEL genes were selected (function
in parenthesis): lipocalin 2 (promotes apoptosis),
angiotensin converting enzyme (ACE, promotes apop-
tosis), Rap2 interacting protein (reduces apoptosis,
promotes proliferation), amphiregulin (promotes pro-
liferation) and leucine-rich-a2-glycoprotein (promotes
apoptosis, reduces proliferation). PCR results
confirmed significant changes between groups. The
significant increase in ACE 1w postoperatively (indi-
cating increased apoptosis in SBR1w vs. Sham1w) and
the increase in Rap2 interacting protein after 4w
(indicating decreased apoptosis in SBR4w vs. SBR1w)
preceded the observed apoptotic changes. The altera-
tions in lipocalin 2 (indicating decreased apoptosis in
Sham4w vs. Sham1w), amphiregulin (indicating
increased proliferation in SBR4w vs. SBR1w) and
leucine-rich-a2-glycoprotein (indicating increased
apoptosis in SBR4w vs. Sham4w) coincided with the
marked homeostatic variations.
Discussion
Epithelial cell (EC) homeostasis is maintained on a day-
to-day basis by a fine balance between EC-proliferation
and -apoptosis. The intestinal mucosa permanently
Fig. 1 BrdU staining of small
bowel biopsies. Proliferation
rate is expressed as the ratio of
BrdU positive cells over the
total number of epithelial cells
(EC) of a crypt-villus complex.
Note the markedly increased
EC-proliferation rate (dark
stained cells) after massive small
bowel resection (SBR4w).
Magnification ·160
Table 2 Changes in rate of epithelial cell (EC)-proliferation,
-apoptosis and -necrosis rate 1 and 4 weeks postoperatively.
Proliferation rate is expressed as the ratio of BrdU positive cells
over the total number of EC of a crypt-villus complex. Apoptotic
rate is detected by gating on EC with flow cytometry and detecting
the percent of Annexin V staining as percentage of total EC. Note
the significant change in proliferation between groups 1 and
4 weeks postoperatively. The apoptotic rate after 4 weeks showed a
persistent elevation in SBR mice and a decline in the sham operated
group. Necrosis showed no significant changes between groups.





rate (% of EC
population)
EC necrosis
rate (% of EC
population)
SBR1w 0.24±0.07 36.0±19.9 11.6±7.1
Sham1w 0.12±0.02* 36.4±10.1 9.6±4.6
SBR4w 0.35±0.04 39.9±6.8 14.6±5.7
Sham4w 0.19±0.02** 12.6±6.4** 12.8±9.3
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works to maintain equilibrium between cell proliferation
and cell death. Apoptosis, a morphologically and bio-
chemically distinct form of cell death, plays an essential
biological role to maintain homeostasis and physiolog-
ical integrity in most tissues. After massive small bowel
resection (SBR) an adaptive response in the residual
intestine with an increased EC-apoptosis and -prolifer-
ation rate has been described [4, 6, 7]. Our results con-
firmed these homeostatic changes.
However, the regulation of gastrointestinal growth
remains unclear, but is known to be induced by many
factors [8]. Intraepithelial lymphocytes (IEL) appear to
play an important role in this intestinal homeostasis by
secreting a variety of cytokines [1, 2, 3]. Among known
IEL factors, KGF, IFN-c, TNF-a or IL-12 are examples
that may mediate proliferation, differentiation and
apoptosis of EC [2, 9, 10, 11, 12]. Upon analysis of our
microarray results we focused on expression of growth-
related genes to determine further factors contributing
to intestinal adaptation after SBR. Five IEL genes were
significantly altered and, based on our results, there is
reason to believe that they have a decisive impact on the
adaptive response post-SBR.
Lipocalin 2 (LC2)
The LC family is a large group of small extracellular
proteins that shows great functional diversity [13]. Only
recently, induction of apoptosis has been revealed as one
of the functions of LC2. In a published study on
hematopoietic cells it was found that secreted LC2 in-
duces and is required for apoptosis [14]. Also in our
study, increase of LC2 expression was coincident with
the increase in EC apoptosis. This finding supports this
newly demonstrated LC2 capacity and suggests a so far
unknown regulatory factor of intestinal growth regula-
tion.
Fig. 2 Flow cytometric analysis
of epithelial cell (EC) apoptosis.
Apoptotic rate is detected by
gating on EC with flow
cytometry and detecting the
percent of Annexin V staining
as percentage of total EC. Cell
necrosis is represented by
propidium iodine positive cells,
without Annexin V staining
(left upper quadrant). Note the
increase in EC apoptosis in
mice 1 week postoperative and
its decline 4 weeks
postoperative in the sham
group with persisting high rate
in SBR4w mice. Necrosis
showed no significant changes
between groups
Table 3 IEL genes with greatest alterations in growth-modifying factors; shown are PCR results. aP <0.05 Sham1w vs. SBR1w, b P
<0.05 Sham4w vs. SBR4w, c P <0.05 Sham1w vs. Sham4w, d P <0.05 SBR1w vs. SBR4w






Function Apoptosis› Apoptosis› Apoptosisfl Proliferation› Apoptosis›
Proliferation› Proliferationfl
Sham 1w mean 0.72±0.65c 0.93±0.10a 0.27±0.17 0.31±0.16 0.57±0.28
SBR 1w mean 0.62±0.13 1.04±0.07 0.18±0.13d 0.18±0.07d 0.54±0.11
Sham 4w mean 0.25±0.22b 0.89±0.06c 0.26±0.08 0.25±0.09 0.34±0.24b
SBR 4w mean 0.45±0.27 1.01±0.24 0.21±0.16 0.25±0.11 0.47±0.21
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Rap2 interacting protein
Rap2 is a small GTP-binding protein that belongs to the
Ras family, which is known to control various cellular
functions [15]. Ras itself has been identified as a key
regulator of both cell proliferation and differentiation
[16], and is involved in decreasing apoptotic signals and
regulating tissue maintenance [17]. Knowledge about
Rap2 and Rap2 interacting protein is limited. However,
it has been shown that Rap2 shares most of the effector
proteins with Ras [18] and equates the function of this
survival factor [19]. We showed a significant increase of
Rap2 interacting protein in IEL of SBR4w mice, which
indicates a possible function in the pathway of the reg-
ulation of intestinal homeostasis.
Amphiregulin (AR)
AR is one of the members of the epidermal growth
factor (EGF) family and has been described as a potent
stimulator of proliferation in a variety of cell types such
as prostatic [20], mammary [21] and colonic epithelial
cells [22]. AR has been shown to be present in a large
number of both malignant and benign colon [22] and
mammary tumors [23]. AR also seems to play an
essential role in the mammary gland development,
whereby AR deficiency leads to impaired mammary
gland function [24]. Our results show an increase of AR
expression in SBR4w mice, matching the observed in-
crease in EC-proliferation and suggesting a possible role
in intestinal adaptation.
Leucine-rich-a2-glycoprotein (LRGP)
Knowledge about the function of LRGP is scarce.
However, in a recent study it has been shown that
LRGP binds transforming growth factor beta (TGF-b)
and may equally be involved in its functional pathway.
TGF-b has been found to be a pro-apoptotic factor in
the murine intestinal mucosa [25], as well as an inhibitor
of cell proliferation [26]. LRGP expression was in-
creased in SBR4w mice, at which time the EC-apoptotic
rate was increased. However, our finding of increased
proliferation in these mice is not consistent with the
anticipated inhibition of cell proliferation by LRGP,
assuming that the TGF-b pathway is followed. Because
of the limited information about LRGP, it may not yet
be possible to draw conclusions.
Angiotensin-converting enzyme (ACE)
ACE has been found to be a mediator in the induction of
apoptosis of alveolar epithelial cells [27], as well as in
non-epithelial cells like myocytes [28] and endothelial
cells [29]. The mechanism by which ACE affects apop-
tosis is not yet clearly understood and seems to include
different pathways. Several studies have described that
with the use of ACE-inhibitors there is a change in the
cytokine expression in lymphocytes [30, 31]. This implies
that ACE may directly induce altered cytokine expres-
sion, potentially in the IEL, which thereafter may induce
apoptosis in EC. ACE may also work via the renin-
angiotensin system by effecting angiotensin II (ANG II),
the product of the conversion of ANG I to II by ACE.
ANGII may induce apoptosis, as seen in alveolar epi-
thelial cells [27]. ACE also acts on the kallikrein-kinin
system, where bradykinin, which is degraded by ACE,
has been shown to have an impact on apoptosis in
endothelial cells and cardiocytes [32, 33]. Recent studies
focused on controlling ACE and its biological effects
utilizing well-established ACE-inhibitors (ACE-I). The
results are remarkable: administration of ACE-inhibi-
tors clearly reduced the apoptotic rate in the above-
mentioned cell types [34, 35, 36]. In our study, the
alterations of the ACE-mRNA expression preceded the
observed apoptotic changes. However, it can be antici-
pated that ACE may have a regulatory function
regarding apoptosis. These findings suggest that
administration of an ACE-inhibitor to SBR mice would
be beneficial. ACE-inhibitors may decrease the apopto-
tic rate of EC and promote the adaptive process after
SBR, support compensation for the loss of mucosal
surface area and basically prevent the short bowel syn-
drome.
These preliminary data show that the IEL undergo
marked temporal changes after SBR. Clearly, more
investigation is needed to further elucidate our findings.
Nevertheless, our results evidently provide novel insight
into potential IEL-dependent regulation of EC homeo-
stasis after massive SBR.
Acknowledgements This work was supported by a grant from the
National Institute of Health, USA (AI44076–01), by fellowships
from Novartis Stiftung Schweiz, Swiss National Foundation, and
the Swiss Society of Pediatric Surgery. Microarray analysis was
supported through the University of Michigan NIDDK Biotech-
nology Center.
References
1. Beagley KW, Husband AJ (1998) Intraepithelial lymphocytes:
origins, distribution, and function. Crit Rev Immunol 18:237–
254
2. Guy-Grand D, Di Santo JP, Henchoz P, Malassis-Seris M,
Vassalli P (1998) Small bowel enteropathy: role of intraepi-
thelial lymphocytes and of cytokines (IL-12, IFN-gamma,
TNF) in the induction of epithelial cell death and renewal. Eur
J Immunol 28:730–744
3. Eisenbraun MD, Mosley RL, Teitelbaum DH, Miller RA
(2000) Altered development of intestinal intraepithelial lym-
phocytes in p-glycoprotein-deficient mice. Dev Comp Immunol
24:783–795
4. Helmrath MA, VanderKolk WE, Can G, Erwin CR, Warner
BW (1996) Intestinal adaptation following massive small bowel
resection in the mouse. J Am Coll Surg 183:441–449
5. Kiristioglu I, Teitelbaum DH (1998) Alteration of the intestinal
intraepithelial lymphocytes during total parenteral nutrition.
J Surg Res 79:91–96
314
6. Welters CF, Dejong CH, Deutz NE, Heineman E (2002)
Intestinal adaptation in short bowel syndrome. ANZ J Surg
72:229–236
7. Falcone RA Jr, Stern LE, Kemp CJ, Shin CE, Erwin CR,
Warner BW (1999) Apoptosis and the pattern of DNase I
expression following massive small bowel resection. J Surg Res
84:218–222
8. Klein RM, McKenzie JC (1983) The role of cell renewal in the
ontogeny of the intestine. J Pediatr Gastroenterol Nutr 2:204–
228
9. Iwakiri D, Podolsky DK (2001) Keratinocyte growth factor
promotes goblet cell differentiation through regulation of
goblet cell silencer inhibitor. Gastroenterology 120:1372–1380
10. Boismenu R, Havran WL (1994) Modulation of epithelial cell
growth by intraepithelial gamma delta T cells. Science
266:1253–1255
11. Barrett T, Gajewski T, Danielpour D, Chang E, Beagley K,
Bluestone J (1992) Differential function of intestinal intraepi-
thelial lymphocyte subsets. J Immunol 149:1124–1130
12. Abreu-Martin MT, Palladino AA, Faris M, Carramanzana
NM, Nel AE, Targan SR (1999) Fas activates the JNK path-
way in human colonic epithelial cells: lack of a direct role in
apoptosis. Am J Physiol 276: G599–605
13. Flower DR (1996) The lipocalin protein family: structure and
function. Biochem J 318:1–14
14. Devireddy LR, Teodoro JG, Richard FA, Green MR (2001)
Induction of apoptosis by a secreted lipocalin that is trans-
criptionally regulated by IL-3 deprivation. Science 293:829–834
15. Janoueix-Lerosey I, Pasheva E, de Tand MF, Tavitian A, de
Gunzburg J (1998) Identification of a specific effector of the
small GTP-binding protein Rap2. Eur J Biochem 252:290–298
16. Janda E, Litos G, Grunert S, Downward J, Beug H (2002)
Oncogenic Ras/Her-2 mediate hyperproliferation of polarized
epithelial cells in 3D cultures and rapid tumor growth via the
PI3 K pathway. Oncogene 21:5148–5159
17. Danielsen AJ, Maihle NJ (2002) The EGF/ErbB receptor
family and apoptosis. Growth Factors 20:1–15
18. Nancy V, Wolthuis RM, de Tand MF, Janoueix-Lerosey I, Bos
JL, de Gunzburg J (1999) Identification and characterization of
potential effector molecules of the Ras-related GTPase Rap2.
J Biol Chem 274:8737–8745
19. Jimenez B, Pizon V, Lerosey I, Beranger F, Tavitian A, de
Gunzburg J (1991) Effects of the Ras-related Rap2 protein on
cellular proliferation. Int J Cancer 49:471–479
20. Sehgal I, Bailey J, Hitzemann K, Pittelkow MR, Maihle NJ
(1994) Epidermal growth factor receptor-dependent stimula-
tion of amphiregulin expression in androgen-stimulated human
prostate cancer cells. Mol Biol Cell 5:339–347
21. Li S, Plowman GD, Buckley SD, Shipley GD (1992) Heparin
inhibition of autonomous growth implicates amphiregulin as
an autocrine growth factor for normal human mammary epi-
thelial cells. J Cell Physiol 153:103–111
22. Johnson GR, Saeki T, Gordon AW, Shoyab M, Salomon DS,
Stromberg K (1992) Autocrine action of amphiregulin in a
colon carcinoma cell line and immunocytochemical localization
of amphiregulin in human colon. J Cell Biol 118:741–751
23. Silvy M, Giusti C, Martin PM, Berthois Y (2001) Differential
regulation of cell proliferation and protease secretion by epi-
dermal growth factor and amphiregulin in tumoral versus
normal breast epithelial cells. Br J Cancer 84:936–945
24. Luetteke NC, Qiu TH, Fenton SE, Troyer KL, Riedel RF,
Chang A, Lee DC (1999) Targeted inactivation of the EGF and
amphiregulin genes reveals distinct roles for EGF receptor li-
gands in mouse mammary gland development. Development
126:2739–2750
25. Dunker N, Schmitt K, Schuster N, Krieglstein K (2002) The
role of transforming growth factor beta-2, beta-3 in mediating
apoptosis in the murine intestinal mucosa. Gastroenterology
122:1364–1375
26. Dignass AU, Sturm A (2001) Peptide growth factors in the
intestine. Eur J Gastroenterol Hepatol 13:763–770
27. Wang R, Zagariya A, Ibarra-Sunga O, Gidea C, Ang E,
Deshmukh S, Chaudhary G, Baraboutis J, Filippatos G, Uhal
BD (1999) Angiotensin II induces apoptosis in human and rat
alveolar epithelial cells. Am J Physiol 276:L885–889
28. Kajstura J, Cigola E, Malhotra A, Li P, Cheng W, Meggs LG,
Anversa P (1997) Angiotensin II induces apoptosis of adult
ventricular myocytes in vitro. J Mol Cell Cardiol 29:859–870
29. Dimmeler S, Rippmann V, Weiland U, Haendeler J, Zeiher
AM (1997) Angiotensin II induces apoptosis of human endo-
thelial cells. Protective effect of nitric oxide. Circ Res 81:970–
976
30. Schindler R, Dinarello CA, Koch KM (1995) Angiotensin-
converting-enzyme inhibitors suppress synthesis of tumour
necrosis factor and interleukin 1 by human peripheral blood
mononuclear cells. Cytokine 7:526–533
31. Constantinescu CS, Goodman DB, Ventura ES (1998) Cap-
topril and lisinopril suppress production of interleukin-12 by
human peripheral blood mononuclear cells. Immunol Lett
62:25–31
32. Kono Y, Sawada S, Kawahara T, Tsuda Y, Higaki T, Yama-
saki S, Imamura H, Tada Y, Sato T, Hiranuma O, Akamatsu
N, Komatsu S, Tamagaki T, Nakagawa K, Tsuji H, Nakagawa
M (2002) Bradykinin inhibits serum-depletion-induced apop-
tosis of human vascular endothelial cells by inducing nitric
oxide via calcium ion kinetics. J Cardiovasc Pharmacol 39:251–
261
33. Yoshida H, Zhang JJ, Chao L, Chao J (2000) Kallikrein gene
delivery attenuates myocardial infarction and apoptosis after
myocardial ischemia and reperfusion. Hypertension 35:25–31
34. Uhal BD, Gidea C, Bargout R, Bifero A, Ibarra-Sunga O,
Papp M, Flynn K, Filippatos G (1998) Captopril inhibits
apoptosis in human lung epithelial cells: a potential antifibrotic
mechanism. Am J Physiol 275:L1013–1017
35. Odaka C, Mizuochi T (2000) Angiotensin-converting enzyme
inhibitor captopril prevents activation-induced apoptosis by
interfering with T cell activation signals. Clin Exp Immunol
121:515–522
36. Yu G, Liang X, Xie X, Su M, Zhao S (2001) Diverse effects of
chronic treatment with losartan, fosinopril, and amlodipine on
apoptosis, angiotensin II in the left ventricle of hypertensive
rats. Int J Cardiol 81:123–129
315
